| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_614ac7bd2272b6c9e3705511e5add40d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-63 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 |
| filingDate |
1979-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1981-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56db4eb5a800117e426f388a10f39a53 |
| publicationDate |
1981-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4247540-A |
| titleOfInvention |
Therapeutic agent |
| abstract |
A Therapeutic Agent, comprising an aqueous extract material from the venom sac of ants from the genus Pseudomyrmex species triplarinus, is injected into a patient with the result that there is a remission of pain and other symptoms due to such auto-immune ailments as rheumatoid arthritis without the discomfort experienced from venom injected into a patient. The active agent is determined to be a composition of a polysaccharide nature. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5506210-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0141182-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4612303-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0056824-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9003178-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4504585-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5180743-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0141182-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102006000672-A1 |
| priorityDate |
1979-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |